Entire field of Alzheimer’s research exposed as FRAUDULENT – longstanding NIH neurology director Eliezer Masliah engaged in data manipulation to benefit drug companies

Entire field of Alzheimer’s research exposed as FRAUDULENT – longstanding NIH neurology director Eliezer Masliah engaged in data manipulation to benefit drug companies Masliah, who was appointed as the director of the National Institute on Aging's (NIA) Division of Neuroscience in 2016, has been a pivotal player in the field, overseeing a budget of $2.6 billion.

NIH officials and their research collaborators have committed data fraud to benefit drug companies for many years now, and the Alzheimer’s research community is collapsing as a result.

Celebrated for his contributions to the understanding of Alzheimer’s and Parkinson’s diseases, Masliah has authored nearly 800 research papers, making him one of the most cited scientists in his discipline.

This research has led to the speedy approval of new Alzheimer’s drugs, but now these drugs are being called into question.

Masliah’s fraudulent research will also impact Neuropore Therapies, which cites Masliah’s work as foundational for its Parkinson’s therapies.

This work contained manipulated images, including Western blots and brain tissue micrographs.

There had to have been ongoing manipulation for years.” Drug companies and scientists who benefited from fraudulent Alzheimer’s research now called into question Following the dossier's release, the NIH stated that Masliah's misconduct was confirmed in two publications, leading to his removal from the NIA’s neuroscience division director position. 

https://www.naturalnews.com/2024-10-07-entire-field-alzheimers-research-exposed-as-fraudulent.html